Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement on the Company’s financial statements - USD ($)								3 Months Ended			6 Months Ended			9 Months Ended	12 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Jun. 30, 2021	Mar. 31, 2021	Mar. 31, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2020	Dec. 31, 2020	Nov. 07, 2019
As Previously Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Common stock subject to possible redemption	$ 120,514,260	$ 120,945,058	$ 121,831,059	$ 123,698,687	$ 123,982,509	$ 124,081,469	$ 123,705,148	$ 120,514,260	$ 120,945,058	$ 124,081,469	$ 120,514,260	$ 123,982,509	$ 123,705,148	$ 123,698,687	$ 121,831,059	$ 112,525,160
Common stock	435	430	424	405	403	402	402	435	430	402	435	403	402	405	424	432
Additional paid-in capital	6,884,301	6,453,508	5,567,513	3,699,904	3,416,084	3,317,125	3,693,446	6,884,301	6,453,508	3,317,125	6,884,301	3,416,084	3,693,446	3,699,904	5,567,513	5,020,136
Accumulated deficit	(1,884,733)	(1,453,933)	(567,927)	1,299,693	1,583,517	1,682,483	1,306,153	(1,884,733)	(1,453,933)	1,682,483	(1,884,733)	1,583,517	1,306,153	1,299,693	(567,927)	(20,567)
Total stockholders’ equity (deficit)	$ 5,000,003	$ 5,000,005	$ 5,000,010	$ 5,000,002	$ 5,000,004	$ 5,000,010	$ 5,000,001	$ 5,000,003	$ 5,000,005	$ 5,000,010	$ 5,000,003	$ 5,000,004	$ 5,000,001	$ 5,000,002	$ 5,000,010	$ 5,000,001
Number of shares subject to redemption (in Shares)	12,032,081	12,066,613	12,133,696	12,321,300	12,358,836	12,358,836	12,353,237	12,032,081	12,066,613	12,358,836	12,032,081	12,358,836	12,353,237	12,321,300	12,133,696	11,252,516
Sale of 13,001,552 Units, net of underwriting discount and offering expenses							$ 126,622,527
Initial value of common stock subject to redemption at IPO							(123,705,148)
Accretion for common stock to redemption amount
Initial classification of common stock subject to possible redemption													$ 122,378,428
Weighted average shares outstanding, Common Stock subject to possible redemption (in Shares)								12,066,613	12,133,696	12,353,237	12,099,969	12,356,037	12,128,362	12,353,612	12,345,490
Basic and diluted net income per share, Common Stock subject to possible redemption (in Dollars per share)										$ 0.04		$ 0.04	$ 0.01	$ 0.05	$ 0.05
Weighted average shares outstanding of Common stock (in Shares)								4,305,327						4,018,328
Weighted average shares outstanding, Common Stock (in Shares)									4,238,244	4,018,703	4,271,971	4,015,904	3,394,029		4,026,450
Basic and diluted net income (loss) income per share, Common stock (in Dollars per share)									$ (0.02)			$ (0.06)
Basic and diluted net loss per share, Common Stock (in Dollars per share)								$ (0.1)	$ (0.15)	$ (0.04)	$ (0.31)		$ 0.33	$ (0.14)	$ (0.6)
Change in value of common stock subject to redemption	430,798	886,001	1,867,628	283,822	98,960	(376,321)
Adjustment [Member]
Condensed Financial Statements, Captions [Line Items]
Common stock subject to possible redemption	9,710,295	9,371,001	8,713,900	6,829,335	6,553,480	6,452,799	6,492,214	$ 9,710,295	$ 9,371,001	$ 6,452,799	$ 9,710,295	$ 6,553,480	$ 6,492,214	$ 6,829,335	$ 8,713,900	$ 7,474,840
Common stock	(98)	(93)	(87)	(68)	(66)	(65)	(65)	(98)	(93)	(65)	(98)	(66)	(65)	(68)	(87)	(75)
Additional paid-in capital	(6,884,301)	(6,453,508)	(5,567,513)	(3,699,904)	(3,416,084)	(3,317,125)	(3,693,446)	(6,884,301)	(6,453,508)	(3,317,125)	(6,884,301)	(3,416,084)	(3,693,446)	(3,699,904)	(5,567,513)	(5,020,136)
Accumulated deficit	(2,825,896)	(2,917,400)	(3,146,300)	(3,129,363)	(3,137,330)	(3,135,609)	(2,798,703)	(2,825,896)	(2,917,400)	(3,135,609)	(2,825,896)	(3,137,330)	(2,798,703)	(3,129,363)	(3,146,300)	(2,454,196)
Total stockholders’ equity (deficit)	$ (9,710,295)	$ (9,371,001)	$ (8,713,900)	$ (6,829,335)	$ (6,553,480)	$ (6,452,799)	$ (6,492,214)	$ (9,710,295)	$ (9,371,001)	$ (6,452,799)	$ (9,710,295)	$ (6,553,480)	$ (6,492,214)	$ (6,829,335)	$ (8,713,900)	$ (7,474,840)
Number of shares subject to redemption (in Shares)	969,471	934,939	867,856	680,252	642,716	642,716	648,315	969,471	934,939	642,716	969,471	642,716	648,315	680,252	867,856	747,484
Sale of 13,001,552 Units, net of underwriting discount and offering expenses							$ (126,622,527)
Initial value of common stock subject to redemption at IPO							123,705,148
Accretion for common stock to redemption amount	$ 91,504	$ 228,900	$ (16,937)	$ 7,967	$ (1,721)	$ (336,906)	(3,574,835)
Initial classification of common stock subject to possible redemption													$ 7,637,092
Weighted average shares outstanding, Common Stock subject to possible redemption (in Shares)								934,939	867,856	(648,315)	901,583	645,515	(7,617,397)	647,940	656,062
Basic and diluted net income per share, Common Stock subject to possible redemption (in Dollars per share)										$ (0.02)		$ (0.02)	$ 0.16	$ (0.05)	$ (0.16)
Weighted average shares outstanding of Common stock (in Shares)								(934,939)						(647,940)
Weighted average shares outstanding, Common Stock (in Shares)									(867,856)	(648,315)	(901,583)	(645,516)	(246,439)		(656,026)
Basic and diluted net income (loss) income per share, Common stock (in Dollars per share)								$ (0.03)	$ (0.03)		$ (0.08)	$ 0.08
Basic and diluted net loss per share, Common Stock (in Dollars per share)								$ 0.07	$ 0.1	$ 0.06	$ 0.23		$ (0.16)	$ 0.14	$ 0.49
Change in value of common stock subject to redemption	(430,798)	(886,001)	(1,867,628)	(283,822)	(98,960)	376,321
As Restated [Member]
Condensed Financial Statements, Captions [Line Items]
Common stock subject to possible redemption	130,224,555	130,316,059	130,544,959	130,528,022	130,535,989	130,534,268	130,197,362	$ 130,224,555	$ 130,316,059	$ 130,534,268	$ 130,224,555	$ 130,535,989	$ 130,197,362	$ 130,528,022	$ 130,544,959	$ 120,000,000
Common stock	337	337	337	337	337	337	337	337	337	337	337	337	337	337	337	357
Additional paid-in capital
Accumulated deficit	(4,710,629)	(4,371,333)	(3,714,227)	(1,829,670)	(1,553,813)	(1,453,126)	(1,492,550)	(4,710,629)	(4,371,333)	(1,453,126)	(4,710,629)	(1,553,813)	(1,492,550)	(1,829,670)	(3,714,227)	(2,475,196)
Total stockholders’ equity (deficit)	$ (4,710,292)	$ (4,370,996)	$ (3,713,890)	$ (1,829,333)	$ (1,553,476)	$ (1,452,789)	$ (1,492,513)	$ (4,710,292)	$ (4,370,996)	$ (1,452,789)	$ (4,710,292)	$ (1,553,476)	$ (1,492,513)	$ (1,829,333)	$ (3,713,890)	$ (2,474,839)
Number of shares subject to redemption (in Shares)	13,001,552	13,001,552	13,001,552	13,001,552	13,001,552	13,001,552	13,001,552	13,001,552	13,001,552	13,001,552	13,001,552	13,001,552	13,001,552	13,001,552	13,001,552	12,000,000
Sale of 13,001,552 Units, net of underwriting discount and offering expenses
Initial value of common stock subject to redemption at IPO
Accretion for common stock to redemption amount	$ 91,504	$ 228,900	$ (16,937)	$ 7,967	$ (1,721)	$ (336,906)	$ (3,574,835)
Initial classification of common stock subject to possible redemption													$ 130,015,520
Weighted average shares outstanding, Common Stock subject to possible redemption (in Shares)								13,001,552	13,001,552	13,001,552	13,001,552	13,001,552	4,510,965	13,001,552	13,001,552
Basic and diluted net income per share, Common Stock subject to possible redemption (in Dollars per share)										$ 0.02		$ 0.02	$ 0.17		$ (0.11)
Weighted average shares outstanding of Common stock (in Shares)								3,370,388						3,370,388
Weighted average shares outstanding, Common Stock (in Shares)									3,370,388	3,370,388	3,370,388	3,370,388	3,147,590		3,370,388
Basic and diluted net income (loss) income per share, Common stock (in Dollars per share)								$ (0.03)	$ (0.05)		$ (0.08)	$ 0.02
Basic and diluted net loss per share, Common Stock (in Dollars per share)								$ (0.03)	$ (0.05)	$ 0.02	$ (0.08)		$ 0.17		$ (0.11)
Change in value of common stock subject to redemption